Article Details

Boston biotech startup Ginkgo in talks to go public via SPAC route in $20bn valuation

Retrieved on: 2021-04-10 18:56:15

Tags for this article:

Click the tags to see associated articles and topics

Boston biotech startup Ginkgo in talks to go public via SPAC route in $20bn valuation. View article details on hiswai:

Excerpt

... such as Bill Gates' Cascade Investment alongside hedge fund Viking Global. ... Aside from that, although the financial terms of the deal had yet to be ...

Article found on: www.financial-world.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up